Haijing Qu

915 total citations
30 papers, 700 citations indexed

About

Haijing Qu is a scholar working on Biomedical Engineering, Biomaterials and Molecular Biology. According to data from OpenAlex, Haijing Qu has authored 30 papers receiving a total of 700 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Biomedical Engineering, 18 papers in Biomaterials and 12 papers in Molecular Biology. Recurrent topics in Haijing Qu's work include Nanoplatforms for cancer theranostics (23 papers), Nanoparticle-Based Drug Delivery (18 papers) and RNA Interference and Gene Delivery (5 papers). Haijing Qu is often cited by papers focused on Nanoplatforms for cancer theranostics (23 papers), Nanoparticle-Based Drug Delivery (18 papers) and RNA Interference and Gene Delivery (5 papers). Haijing Qu collaborates with scholars based in China, United States and Italy. Haijing Qu's co-authors include Xiangdong Xue, Yuanpei Li, Wei Cheng, Han Chen, Lijia Jing, Xing Jin, Ying Zhang, Yang Wang, Jian Zheng and Xiufeng Yan and has published in prestigious journals such as Advanced Materials, SHILAP Revista de lepidopterología and Nano Letters.

In The Last Decade

Haijing Qu

30 papers receiving 694 citations

Peers

Haijing Qu

BIOMA

IMMUN

Hai‐Yi Feng China

Mao‐Hua Zhu China

Si‐Cong Yang China

Zhaoming Guo China

Xianping Liu China

Alexey V. Yaremenko Russia

Ann T. Chen United States

Jingxing Si China

Jessica A. Kemp United States

Hai‐Yi Feng China

Haijing Qu

434 ×1.0

264 ×0.8

BIOMA

207 ×0.8

162 ×1.4

83 ×1.0

IMMUN

Citations per year, relative to Haijing Qu Haijing Qu (= 1×) peers Hai‐Yi Feng

Countries citing papers authored by Haijing Qu

Since Specialization

Citations

This map shows the geographic impact of Haijing Qu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Haijing Qu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Haijing Qu more than expected).

Fields of papers citing papers by Haijing Qu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Haijing Qu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Haijing Qu. The network helps show where Haijing Qu may publish in the future.

Co-authorship network of co-authors of Haijing Qu

This figure shows the co-authorship network connecting the top 25 collaborators of Haijing Qu. A scholar is included among the top collaborators of Haijing Qu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Haijing Qu. Haijing Qu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Cheng, Wei, Jiaojiao Yang, Yuqing Pan, et al.. (2025). Noninvasive Activation of Local and Systemic Immunity with a Sequential-Targeting Sonodynamic Nanovaccine to Treat Glioblastoma. ACS Nano. 19(30). 27804–27824. 5 indexed citations

Wu, Jie, Xiangdong Xue, & Haijing Qu. (2025). Tumor microenvironment-responsive nanoplatforms for enhanced cancer immunotherapy: Advances and synergistic strategies. SHILAP Revista de lepidopterología. 4. 100092–100092. 5 indexed citations

Cheng, Wei, Haijing Qu, Jiaojiao Yang, et al.. (2025). Hierarchically Engineered Self-Adaptive Nanoplatform Guided Intuitive and Precision Interventions for Deep-Seated Glioblastoma. ACS Nano. 19(1). 557–579. 6 indexed citations

Wu, Jie, Yuqing Pan, Haijing Qu, et al.. (2025). Blocked bioorthogonal chemistry enabled switchable bioorthosome to improve liposomal drug delivery for glioblastoma therapy. Nano Research. 18(4). 94907338–94907338. 2 indexed citations

Wang, Yanjun, Hui Dong, Haijing Qu, et al.. (2024). Biomimetic Lung-Targeting Nanoparticles with Antioxidative and Nrf2 Activating Properties for Treating Ischemia/Reperfusion-Induced Acute Lung Injury. Nano Letters. 24(7). 2131–2141. 14 indexed citations

Chen, Han Y. H., Haijing Qu, Yuqing Pan, et al.. (2024). A metal-coordination stabilized small-molecule nanomedicine with high drug-loading capacity and synergistic photochemotherapy for cancer treatment. Nanoscale. 16(31). 14734–14747. 4 indexed citations

Qu, Haijing, Jie Wu, Yuqing Pan, et al.. (2024). Biomimetic Nanomodulator Regulates Oxidative and Inflammatory Stresses to Treat Sepsis-Associated Encephalopathy. ACS Nano. 18(41). 28228–28245. 17 indexed citations

Chen, Han, Haijing Qu, Yuqing Pan, Wei Cheng, & Xiangdong Xue. (2024). Manganese-coordinated nanoparticle with high drug-loading capacity and synergistic photo-/immuno-therapy for cancer treatments. Biomaterials. 312. 122745–122745. 27 indexed citations

Qu, Haijing, Jinfan Yang, Xin Zhou, et al.. (2023). Programmed-response cross-linked nanocarrier for multidrug-resistant ovarian cancer treatment. Journal of Controlled Release. 357. 274–286. 11 indexed citations

10.

Xue, Xiangdong, Haijing Qu, Ruonan Bo, et al.. (2023). A transformable nanoplatform with multiple therapeutic and immunostimulatory properties for treatment of advanced cancers. Biomaterials. 299. 122145–122145. 19 indexed citations

11.

Qu, Haijing, Han Chen, Wei Cheng, et al.. (2023). A supramolecular assembly strategy for hydrophilic drug delivery towards synergistic cancer treatment. Acta Biomaterialia. 164. 407–421. 23 indexed citations

12.

Qu, Haijing, Han Chen, Menghuan Tang, et al.. (2023). Drug-drug conjugates self-assembled nanomedicines triggered photo−/immuno- therapy for synergistic cancer treatments. Journal of Controlled Release. 363. 361–375. 25 indexed citations

13.

Qu, Haijing, Xing Jin, Wei Cheng, et al.. (2023). Uncovering the Fate and Risks of Intravenously Injected Prussian Blue Nanoparticles in mice by an Integrated Methodology of Toxicology, Pharmacokinetics, Proteomics, and Metabolomics. Particle and Fibre Toxicology. 20(1). 18–18. 6 indexed citations

14.

Li, Guoyin, Zewen Song, Yi Ru, et al.. (2023). Small‐molecule nanoprodrug with high drug loading and EGFR, PI3K/AKT dual‐inhibiting properties for bladder cancer treatment. SHILAP Revista de lepidopterología. 3(5). 20220141–20220141. 31 indexed citations

15.

Xue, Xiangdong, Haijing Qu, & Yuanpei Li. (2022). Stimuli‐responsive crosslinked nanomedicine for cancer treatment. SHILAP Revista de lepidopterología. 2(6). 20210134–20210134. 136 indexed citations

16.

Zhang, Ying, Haijing Qu, & Xiangdong Xue. (2021). Blood–brain barrier penetrating liposomes with synergistic chemotherapy for glioblastoma treatment. Biomaterials Science. 10(2). 423–434. 44 indexed citations

17.

Wu, Hao, Hongwei Lu, Wenwu Xiao, et al.. (2020). Sequential Targeting in Crosslinking Nanotheranostics for Tackling the Multibarriers of Brain Tumors. Advanced Materials. 32(14). e1903759–e1903759. 64 indexed citations

18.

Xue, Xiangdong, Haijing Qu, Aaron Lindstrom, et al.. (2020). Iron-crosslinked Rososome with robust stability and high drug loading for synergistic cancer therapy. Journal of Controlled Release. 329. 794–804. 14 indexed citations

19.

Xue, Xiangdong, Aaron Lindstrom, Haijing Qu, & Yuanpei Li. (2019). Recent advances on small‐molecule nanomedicines for cancer treatment. Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology. 12(3). e1607–e1607. 19 indexed citations

20.

Ding, Weimin, Sheng Zhang, Shaoming Wang, et al.. (2017). A 3D-QSAR Study on Betulinic Acid Derivatives as Anti-Tumor Agents and the Synthesis of Novel Derivatives for Modeling Validation. Anti-Cancer Agents in Medicinal Chemistry. 17(4). 566–575. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact